CSF and Plasma Biomarkers in Patients With Iatrogenic Cerebral Amyloid Angiopathy.
Giuliana PollaciAntonella PotenzaGemma GorlaTatiana CarrozziniGiulia MarinoniCarolina De TomaIsabella CanaveroNicola RifinoGiorgio B BoncoraglioDiFrancesco Jacopo CosimoPayam Tabaee DamavandiMario StanzianoAlessandra ErbettaPaola CaroppoGiuseppe Di FedeMarcella CataniaAida ZuluetaEugenio Agostino ParatiAnna BersanoLaura GattiBenedetta StortiPublished in: Neurology (2024)
Despite presenting with a younger age at onset, fewer cardiovascular risk factors, and lower cognitive impairment, patients with iCAA demonstrated Aβ and tau levels comparable with elderly patients with sCAA, supporting a common molecular paradigm between the 2 CAA forms.